ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jun 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
July 2025
Latest News
Orano Med expands its Texas Pb-212 R&D center
Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The facility is used in the development of radiopharmaceuticals and for conducting preclinical research focused on targeted alpha therapies using lead-212, an alpha-emitting radioisotope that has shown promise in treating various types of cancer.
Technical Session|Panel|Sponsored by OPD
Tuesday, November 15, 2022|10:00–11:45AM MST|Bougainvillea
Session Chair:
Brian K. Grimes
Session Organizer:
Alternate Chair:
Michelle Catts (GE-Hitachi)
Developing the necessary structure and capabilities of a regulatory body for a comprehensive, independent safety assessment of NPP designs needs substantial time and resources. In many cases, neither sufficient time nor sufficient resources will be available for countries embarking in nuclear power now with the aim to supply carbon free energy in the near future. The panel members will present and discuss various options for the use of Third-Party oversight of design, construction and operation with a particular focus on how the deployment of nuclear power reactors can be enabled for newcomer countries. Examples of options to be discussed are: the model already established by Lloyd's Register in the shipping industry as pseudo-regulators for design, construction, and operation, with some experience in the assurance of nuclear-powered submarines; a concept for an Independent Technical Support Organization funded by major national regulatory bodies; a concept for a Third-Party review funded by the reactor vendor; a concept for the informed adoption of safety assessments or design approvals by well-established regulatory bodies. The role international organizations could play in these approaches will also be addressed.
To access session resources, you must be logged in and registered for the meeting.
Register NowLog In
To join the conversation, you must be logged in and registered for the meeting.
